NEO analyst estimates
NeoGenomics (NEO) analyst ratings, the average price target and its range, and every firm's latest call.
NEO analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Jefferies | NeoGenomics price target raised to $21 from $16.50 at Jefferies | $21.00 |
| Oct 6, 2026 | BTIG | BTIG Upgrades Neogenomics (NEO) to Buy | $28.00 |
| Oct 6, 2026 | Needham | Neogenomics (NEO) PT Raised to $22 at Needham | $22.00 |
| Jul 29, 2026 | Craig-Hallum | NeoGenomics price target raised to $19 from $17 at Craig-Hallum | $19.00 |
| Apr 29, 2026 | Leerink Partners | Leerink upgrades NeoGenomics to Outperform, raises target to $25 | $25.00 |
| Feb 24, 2026 | Piper Sandler | NeoGenomics price target raised to $13 from $12 at Piper Sandler | $13.00 |
| Oct 28, 2025 | Leerink Partners | NeoGenomics price target raised to $14 from $12 at Leerink | $14.00 |
| Sep 2, 2025 | Stephens | NeoGenomics price target raised to $11 from $6.50 at Stephens | $11.00 |
| Aug 4, 2025 | Piper Sandler | NeoGenomics price target lowered to $11 from $12 at Piper Sandler | $11.00 |
| Jul 30, 2025 | Morgan Stanley | NeoGenomics price target lowered to $8 from $10 at Morgan Stanley | $8.00 |
| Jul 29, 2025 | Needham | Neogenomics (NEO) PT Lowered to $8 at NeedhamMember Login | $8.00 |
| May 6, 2025 | Piper Sandler | NeoGenomics price target lowered to $12 from $18 at Piper Sandler | $12.00 |
| Jan 11, 2025 | BTIG | NeoGenomics price target lowered to $18 from $21 at BTIG | $18.00 |
| Jul 30, 2024 | Needham | Needham Reiterates Buy Rating on Neogenomics (NEO) | $19.00 |
| May 2, 2024 | BTIG | Neogenomics (NEO) PT Lowered to $21 at BTIG | $21.00 |
- 7 firms rate NEO: 7 buy, 0 hold, 0 sell.
- The average price target is $22.50 from 4 analysts, from $19.00 to $28.00.
Updated 2026-11-02 23:58 UTC